Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
American Heart Journal|December 9, 2008
Percutaneous coronary implantation of sirolimus-eluting stents in unselected patients and lesions: clinical results and multiple outcome predictorsGiuseppe Sangiorgi, Enrico Romagnoli, Giuseppe Biondi-Zoccai, et al.Journal of the American College of Cardiology|August 16, 2005
Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilationLei Ge, Flavio Airoldi, Ioannis Iakovou, et al.Circulation|February 21, 2007
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategiesCarlo Briguori, Flavio Airoldi, Davide D'Andrea, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 10, 2006
A novel approach to chronic total occlusions: the crosser systemGloria Melzi, John Cosgrave, Giuseppe L Biondi-Zoccai, et al.European Heart Journal|April 9, 2005
Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusionsLei Ge, Ioannis Iakovou, John Cosgrave, et al.Journal of the American College of Cardiology|April 6, 2005
Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcomeLei Ge, Ioannis Iakovou, Giuseppe M Sangiorgi, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 10, 2009
Appraising the effectiveness and safety of paclitaxel-eluting stents in over 1,000 very high-risk patients: overall results of the Taxus in Real-life Usage Evaluation (TRUE) registryGiuseppe M Sangiorgi, Giuseppe G L Biondi-Zoccai, Pierfrancesco Agostoni, et al.International Journal of Cardiology|July 25, 2006
Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) StudyGiuseppe G L Biondi-Zoccai, Giuseppe M Sangiorgi, David Antoniucci, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
Safety and feasibility of Bivalirudin with either Cypher and Taxus drug-eluting stent during percutaneous coronary interventionAlaide Chieffo, Gloria Melzi, Renata Rogacka, et al.Irish Journal of Medical Science|July 9, 2022
Intravascular lithotripsy-assisted PCI for severely calcified coronary lesions: evaluating the impact on quality of life and outcomesAnthony J Buckley, John P McCormick, James Carey, et al.Pageof 7